quinazolines has been researched along with hymecromone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
House, L; Liu, Y; RamÃrez, J; Ratain, MJ | 1 |
Aungst, RA; Austin, CP; Goldin, E; Lea, WA; Leister, W; Marugan, JJ; Motabar, O; Sidransky, E; Simeonov, A; Southall, N; Stubblefield, BK; Westbroek, W; Zheng, W | 1 |
2 other study(ies) available for quinazolines and hymecromone
Article | Year |
---|---|
Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bilirubin; Binding, Competitive; Biocatalysis; Cell Line; Child; Drug Interactions; Erlotinib Hydrochloride; Female; Gefitinib; Glucuronic Acid; Glucuronosyltransferase; Humans; Hymecromone; Imipramine; Indinavir; Isoenzymes; Kinetics; Male; Microsomes, Liver; Middle Aged; Models, Biological; Protein Kinase Inhibitors; Quinazolines; Recombinant Proteins; Young Adult | 2010 |
Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity.
Topics: Cell Line; Fibroblasts; Gaucher Disease; Glucosylceramidase; Humans; Hymecromone; Immunohistochemistry; Lysosomes; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Molecular Chaperones; Quinazolines; Spectrometry, Mass, Electrospray Ionization; Spleen; Structure-Activity Relationship | 2011 |